Effective treatment of TNFα inhibitors in Chinese patients with Blau syndrome

Effective treatment of TNFα inhibitors in Chinese patients with Blau syndrome

Abstract Objectives Blau syndrome (BS) is a rare dominantly inherited autoinflammatory disorder associated with mutations in the nucleotide-binding oligomerization domain containing 2 (NOD2) gene. Biologic therapy of BS yielded diverse results. We aimed to evaluate clinical features and outcomes of...

Full description

Bibliographic Details
Main Authors: Jing Chen, Yi Luo, Mengzhu Zhao, Di Wu, Yunjiao Yang, Wen Zhang, Min Shen
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Arthritis Research & Therapy
Subjects:
Systemic autoinflammatory diseases
Nucleotide-binding oligomerization domain
Blau syndrome
TNFα inhibitors
Online Access:http://link.springer.com/article/10.1186/s13075-019-2017-5

Internet

http://link.springer.com/article/10.1186/s13075-019-2017-5

Similar Items